It was first demonstrated in breast cancer models that SORL1 could bind to human epidermal growth factor receptor 2 (HER2) in the plasma membrane and intracellular vesicles, which regulates the endosomal trafficking and subcellular distribution of HER2 [7]. Here, ERBB2 is linked to breast cancer.